Your browser doesn't support javascript.
loading
Targeted Therapy to ß3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases.
Fox, Gregory C; Su, Xinming; Davis, Jennifer L; Xu, Yalin; Kwakwa, Kristin A; Ross, Michael H; Fontana, Francesca; Xiang, Jingyu; Esser, Alison K; Cordell, Elizabeth; Pagliai, Kristen; Dang, Ha X; Sivapackiam, Jothilingam; Stewart, Sheila A; Maher, Christopher A; Bakewell, Suzanne J; Fitzpatrick, James A J; Sharma, Vijay; Achilefu, Samuel; Veis, Deborah J; Lanza, Gregory M; Weilbaecher, Katherine N.
Afiliação
  • Fox GC; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Su X; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Davis JL; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Xu Y; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Kwakwa KA; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Ross MH; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Fontana F; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Xiang J; Department of Medicine, Division of Cardiology, Washington University School of Medicine, St. Louis, Missouri.
  • Esser AK; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Cordell E; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Pagliai K; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Dang HX; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Sivapackiam J; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Stewart SA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Maher CA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Bakewell SJ; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Fitzpatrick JAJ; ICCE Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Sharma V; Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Achilefu S; ICCE Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Veis DJ; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Lanza GM; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
  • Weilbaecher KN; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
Mol Cancer Ther ; 20(6): 1183-1198, 2021 06.
Article em En | MEDLINE | ID: mdl-33785647

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Neoplasias da Mama / Integrina beta3 Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Neoplasias da Mama / Integrina beta3 Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article